MicroRNA Market To Reach $3.64 Billion By 2030 | CAGR: 12.87%

MicroRNA Market Growth & Trends

The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

 Request a free sample copy or view report summary: MicroRNA Market Report

MicroRNA Market Report Highlights

• Based on products & services, the services segment dominated the market with the highest revenue share of 58.8% in 2023, due to its ability to provide wide services such as isolation & purification, miRNA cDNA synthesis, profiling, localization, & quantification, functional analysis, and others

• Based on application, the cancer segment dominated the segment with the highest revenue share in 2023, due to high investments in cancer research adopting miRNA signatures

• Based on end-use, the biotechnology & pharmaceutical companies segment dominate the market with the highest revenue share in 2023, due to their ability to establish collaborations and partnerships with research institutions that allow them to access cutting-edge research and collaborate on large-scale projects

• North America dominated the global industry in 2023 owing to the presence of key market players in the region

MicroRNA Market Segmentation

Grand View Research has segmented the global MicroRNA market based on products & services, application, end-use, and region:

MicroRNA Products & Services (Revenue, USD Million, 2018 - 2030)

• Services

  • Type

    • Isolation & Purification

    • miRNA cDNA Synthesis

    • Profiling, Localization, & Quantification

    • Functional Analysis

    • Others

  • Specimen

    • Whole Blood

    • Serum

    • Plasma

    • FFPE

    • Fresh Frozen Tissue

    • Others

• Products

  • Instruments

    • Technology

      • Real Time PCR

      • Microarray

      • NGS

      • Others

    • Workflow

      • Isolation & Purification

      • miRNA cDNA Synthesis

      • Profiling, Localization, & Quantification

      • Functional Analysis & Others

      • Others

  • Consumables

    • Specimens

      • Whole Blood

      • Serum

      • Plasma

      • FFPE

      • Fresh Frozen Tissue

      • Others

    • Workflow

      • Isolation & Purification

      • miRNA cDNA Synthesis

      • Profiling, Localization, & Quantification

      • Functional Analysis

      • Others

MicroRNA Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer

• Infectious Diseases

• Immunological Disorder

• Cardiovascular Disease

• Neurological Disease

• Others

MicroRNA End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology & Pharmaceutical Companies

• Academic & Government Research Institutes

• Others

MicroRNA Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the MicroRNA Market

• Thermo Fisher Scientific, Inc.

• QIAGEN

• Horizon Discovery Group plc.

• NanoString Technologies, Inc.

• Merck KGaA

• Takara Bio, Inc.

• LGC Limited

• BioGenex

• GeneCopoeia, Inc.

• New England Biolabs